Josh Davis

Doctor of Physical Therapy specializes in outpatient neuro PT

[APTA Georgia @apta_ga]

We kick off tomorrow! 🎉
Safe travels to everyone attending the APTA Georgia Impact Conference 2026.
Drop a comment if you’ll be there 👇

[WitnessLens @WitnessLens]

🛠️ Just now we launched the $WITNESS token,
for the @EasyA_Kickstart Solana Hackathon on https://t.co/wC0kDqVcSy platform.

Whitepaper in 1st comment reply below.

The story behind it, why we built this, who it's for, and what comes next.

Episode 1 of Chain Craft. A new series for builders shipping real utility on Solana and XRPL.

Built by Crumby Labs x Axiom Logic LLC

https://t.co/8tgrCxeafX

[Dom Kwok | EasyA @dom_kwok]

crypto is the future and we will not stop until that future is built 🫡💪

[Josh Davis @DoctorJoshD]

@First_StepPT is looking for a PT/PTA to join the First Step Family. #Roswell #Marietta #Fayetteville #physicaltherapy

[Josh Davis @DoctorJoshD]

@UHC is still using @Optum to perform medical review audits. @WebPT will not let a #PhysicalTherapist close a note without timed documentation yet the reviews are #denied saying “does not meet the timed-service documentation requirements “ can someone assist?

[Josh Davis @DoctorJoshD]

Our office park carried #hartford #insurance policy that cost $35959 annually. As soon as we filed a claim on the roof for hail damage the policy was not renewed. What is the purpose of having insurance if you can’t use it without penalty of losing coverage?

[Josh Davis @DoctorJoshD]

@IH_news since implementing preauthorization in October #independent #health denying patients post stoke, spinal cord injury, brain injury, cerebral palsy and other neurological disorders #physicaltherapy services #MedicareAdvantage #insurance

[Josh Davis @DoctorJoshD]

@Aetna recouping payments from 2022 saying the claims were processed during #liberalization that was in effect 4/5/22-5/5/22 and now they are reversing the decision and taking money because a “liberalization was not in place”

[Josh Davis @DoctorJoshD]

Pretty sure the #Missouri QB was sitting on the ground with the ball in his hands before
#oregon ripped it out

[Josh Davis @DoctorJoshD]

@IH_news Independent Health now requiring pre-authorization for physical therapy. 1-2 visits were authorized for patients with diagnosis of stroke, Parkinson’s, spinal cord injury, cerebral palsy. How can we get more visits approved to get these patients the PT they need?

[Josh Davis @DoctorJoshD]

Why are oral-b floss pick terrible now…used to be great. Now have to through 3-4 a night …used to be just 1…what happened?

[Josh Davis @DoctorJoshD]

@UHC denied physical therapy claims for a patient with a spinal cord injury notes saying “does not meet the timed service documentation” @WebPT does not allow completion of a note without “timed service documentation” The PT also manually wrote in the times. Who is reviewing?

[Atlanta Falcons @AtlantaFalcons]

Dawg win = @JalonWlaker giveaway

RT for a chance to win this signed @GeorgiaFootball mini helmet!

[Josh Davis @DoctorJoshD]

Meet Josh Davis of First Step Physical Therapy - https://t.co/LU32tEANY6

[Josh Davis @DoctorJoshD]

How is @UHC able to consistently deny payment with false reasons? “No timed documentation” “5 units”
appeal letter with clear documentation showing these are untrue statements yet still gets denied. #Insurance

[Josh Davis @DoctorJoshD]

Does @UHC reimburse for code 97530 or just deny saying “not supported by documentation “?

[Josh Davis @DoctorJoshD]

@UHC pattern of denial for code 97535 saying “not supported by documentation” …. Is documentation not being read?
Are there any other codes that @UHC denies for no reason?

[Josh Davis @DoctorJoshD]

Just had a 2nd appeal denied by @UHC after providing additional letter of support and original daily note describing the therapist skilled procedure performed and patient activities performed.

[Josh Davis @DoctorJoshD]

@1stStepPT has been seeing excellent results with the ARC-EX

[ONWARD Medical @onwdempowered]

Thank you @nbcchicago and @ReginaWaldroup for shining a light on the life-changing potential of our ARC-EX System. 🙏

In Willow Springs, Next Steps Chicago is helping people like Bari Rubenstein rediscover strength, sensation, and hope. After 14 years as a quadriplegic, Bari’s words say it all:

“It feels like someone turned on a button and forgot to turn it off.”

The ARC-EX System is now available in rehabilitation clinics across the US.

For the complete story, visit here: https://t.co/jg5s9n1Wu9

To be kept informed about the Company’s technologies, research studies, and the availability of therapies in your area, please complete this webform: https://t.co/QMOHDNsfwp

#ThankYou #NBCChicago #ARCEX #SpinalCordInjury #NextStepsChicago #Neurotechnology #HopeInRecovery #HealthTech #EmpoweringMovement

ARC-EX Indication for Use (US): The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).

Other Investigational Products: All other ONWARD Medical devices and therapies including ARC-IM and ARC-BCI are investigational and not available for commercial use.

[ONWARD Medical @onwdempowered]

ONWARD Medical: 2024 Year in Review & 2025 Highlights

2024 was truly transformative for ONWARD as we achieved FDA authorization and first commercial sales of our breakthrough ARC-EX® System for people with spinal cord injury. Here's a look at our incredible journey throughout 2024 and early 2025:

Commercial Achievements
✅ Received FDA De Novo authorization for our ARC-EX System in December 2024
✅ Recorded first commercial sales to @UWMedicine and Next Steps Chicago
✅ ARC-EX System named one of @TIME Magazine's Best Inventions of 2024
✅ Added to US @DeptVetAffairs procurement platforms in January 2025

Clinical and Development Milestones
✅ Received 10th FDA Breakthrough Device Designation for investigational ARC-BCI® System
✅ Accepted into @US_FDA's Total Product Lifecycle Advisory Program for ARC-BCI System
✅ Published Up-LIFT pivotal trial results in @NatureMedicine, meeting all endpoints
✅ Secured exclusive license to WIMAGINE® BCI technology from @CEA_Officiel
✅ First-in-human use of our investigational ARC-IM® Lumbar Lead in March 2025
✅ Awarded grants from @ReeveFoundation , @EUeic, @MichaelJFoxOrg, and the US @DeptofDefense

Corporate Developments
✅ Secured strategic investment from @ottobockHQ_en, acquiring ~10% of our share capital
✅ Strengthened our balance sheet through EUR 70M in equity financing
✅ Signed debt financing agreement for up to EUR 52.5M with Runway Growth Capital
✅ Added @euronext Paris listing, highlighting our strong French connections
✅ Welcomed @RobtenHoedt as new Board Chairman
✅ Added 20 patents to our IP portfolio, now totaling 150+ issued patents*
✅ Awarded silver medal for sustainability by @ecovadis
✅ Ended 2024 with EUR 60.0M net cash

We're excited to continue our momentum in 2025 as we work to restore movement, function, and independence in people with spinal cord injury and other movement disabilities.

A recording of the Full Year Results webcast held today is available on our investor website.

To be kept informed about the Company’s technologies, research studies, and the availability of therapies in your area, please complete this webfore: https://t.co/7wNxGmm9RV

#OnwardMedical #HealthcareInnovation #SpinalCordInjury #MedicalBreakthrough #EmpoweringMovement

*This does not account for country validations; the number of patents including such validations exceeds 290

Investigational products: The ONWARD ARC-IM System and ARC-BCI System are investigational and not available for commercial use.

ARC-EX Indication for Use (US): The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).